1. Introduction {#sec0005}
===============

On Dec 31, 2019, the government of Hubei Province, China, first reported a group of confused patients with pneumonia ([@bib0050]). Metagenomics sequencing analysis revealed a novel coronavirus, which was officially named SARS-CoV-2 and is the cause of the disease called COVID-19 ([@bib0065]). The National Health Commission (NHC) established COVID-19 as a category B infectious disease with A-class management on Jan 20 ([@bib0050]). Furthermore, on Jan 30, the WHO issued a Public Health Emergency of International Concern (PHEIC) alarm and appealed to specialists all over the world to work together to control the rapid spread of COVID-19. As of Mar 8, there had been 80,859 confirmed COVID-19 patients in China, including 3,100 deaths. Internationally, over 100 countries have now reported laboratory-confirmed cases, including a total of 24,031 cases ([@bib0070]). As of March 27, 2020, the World Health Association reports that there are 465,915 confirmed cases of COVID-19 worldwide; 21,031 have died, a mortality rate of about 4.5%.

The first clinical data from 41 individuals with a confirmed diagnosis of COVID-19 from Wuhan, China, have been published ([@bib0020]). Most of them had been directly exposed to the Wuhan wholesale seafood market, which sells freshly slaughtered game animals that were the original infection source ([@bib0020]). The present data strongly suggest that game animals or mammals were probably intermediate hosts of SARS-CoV-2 that originated from the Chinese horseshoe bat ([@bib0085], [@bib0025]). The virus has preferential tropism to human airway epithelial cells through the same cellular receptor as that for SARS, angiotensin-converting enzyme 2 (ACE2), which is a central body receptor for the surface glycoprotein S of the virus ([@bib0030]). The way to ascertain disease depends on positive real-time reverse transcription-polymerase chain reaction (rRT-PCR) results for SARS-CoV-2 nucleic acid. The associated mortality rates are 2-3% ([@bib0070], [@bib0015]). Currently, there are no definite antiviral therapies or vaccines for COVID-19, although some drugs are under investigation.

With the extensive outbreak of COVID-19, a mass of studies in the larger population have been reported. Obviously, the total number of cases and transmission events have far exceeded those of SARS and H1N1. [@bib0075] found that the mean R~0~ of COVID-19 was approximately 2.68 (95% CI: 2.47-2.86). An increasing number of outbreaks of familial transmission stressed the possibility of person-to-person transmission ([@bib0010], [@bib0045], [@bib0040]). The measures in which public health officials quarantine confirmed cases and isolate intimate patients are significant progress in controlling COVID-19. Another question for consideration is a group of asymptomatically infected individuals, which may propagate the virus and impede infection control ([@bib0085], [@bib0080]). [@bib0005] presented clinical data showing a familial cluster of five patients with COVID-19 and one asymptomatic family member, which presumed the possibility of infection from asymptomatic carriers.

In this study, we report the clinical features of a family cluster involving five COVID-19 cases in Luzhou. Three cases came from Wuhan, and the other two cases had not left Luzhou recently. Our data further verified the delivery of infection from asymptomatic carriers of COVID-19 during the incubation period.

2. Methods {#sec0010}
==========

On Feb. 4, a 50-year-old woman (Case 1) was admitted to the People\'s Hospital of Luxian County (Luzhou, Sichuan Province, China) with fever, dizziness, cough, and shortness of breath. On examination, her maximum temperature was 39. 1 °C, and her blood pressure was 152/93 mmHg. A chest CT scan revealed massive shadows of high density in the lungs. The local CDC performed rRT-PCR tests for SARS-CoV-2 nucleic acid, and a throat swab was positive (Ct values, 19). Case 1 was diagnosed and immediately isolated.

Subsequently, forty-four other intimate contacts were admitted to our hospital for a general physical examination on Feb. 5. The local CDC ascertained that the nasopharyngeal or oropharyngeal swabs were positive for four cases (Case 2/3/4/5) according to the SARS-CoV-2 nucleic acid test ([Table 2](#tbl0010){ref-type="table"}). All cases were admitted to the hospital and treated in isolation. A detailed data collection for the five patients was executed, and all patients underwent chest CT imaging. All the laboratory procedures for clinical samples have been previously reported ([@bib0055]). Nasopharyngeal and oropharyngeal swabs and stool and urine samples were obtained and maintained viral transport medium. Plasma was separated from EDTA bottles, and serum was separated from clotted blood bottles. Specimens were held between 2 °C and 8 °C and sent to the CDC. RRT-PCR tests for SARS-CoV-2 nucleic acid were performed by the local CDC; the detection reagents were from Maccura Biotechnology Co., Ltd, and Sansure Biotechnology Co., Ltd.

The Ethics Committee of the People\'s Hospital of Luxian County approved this study. We obtained written consent from all the patients about clinical data, radiographic pictures, information, etc.

3. Results {#sec0015}
==========

We documented and analyzed the clinical symptoms, laboratory results, and history of five cases with verified COVID-19, as presented in [Table 1](#tbl0005){ref-type="table"} . The relationship between the five cases and their general information is shown in [Fig. 3](#fig0015){ref-type="fig"} .Table 1Summary of clinical features and laboratory results of a family cluster infected with COVID-19.Table 1Case 1Case 2Case 3Case 4Case 5RelationshipMother of Case 2Son of Case 1Father of Case 5Mother of Case 5Son of Case3 and 4Age (years)5028505123SexFemaleMaleMaleFemaleMaleOccupationFarmerWorkerTraderTraderTraderChronic medical illnessHypertension, emphysemaNoneNoneNoneNone  *Presenting symptoms and signs*Fever+−+ (hospital exposure)−+ (hospital exposure)Cough+−+ (hospital exposure)−+ (hospital exposure)Dizziness+−−−−Shortness of breath+−−−−Stuffiness−−−−−Diarrhoea−−−+ (hospital exposure)−Pharyngalgia−−−+ (hospital exposure)−Body temperature (°C)39.136.238.2 (hospital exposure)37.038.0 (hospital exposure)Oximetry saturation (%)low 90% (hospital exposure)94%92%92%98%White blood cell count (×10^9^ cells/L) (normal range 4.00--10.00)12.4 (↑)6.129.577.448.24Neutrophil count (×10^9^ cells/L) (normal range 1.80--6.30)7.82 (↑)3.574.115.253.13Lymphocyte count (×10^9^ cells/L) (normal range 1.10--3.20)0.84 (↓)1.03 (↓)1.07 (↓)1.702.46Haemoglobin (g/dL); (normal range 120--160)140152166 (↑)147164 (↑)Platelet count (×10^9^ cells/L) (normal range 100--300)88 (↓)15618772 (↓)242C-reactive protein (mg/L) (normal range 0.0--5.0)189.2 (↑)10.5 (↑)9.0 (↑)43.5 (↑)24.7 (↑)[^2]Fig. 3The relationship between the 5 cases and their general information.Fig. 3

Case 1, a 50-year-old woman, had lived in Luzhou year-round and had hypertension and chronic emphysema disease. Between Jan 23 and Jan 25, she attended the family reunion dinner with her family members (Case 2/3/4/5). On Jan 30, they celebrated the Spring Festival together. Because of the limits on access, Case 1 could not leave her hometown in the countryside, where there had been no previous reports of COVID-19. Furthermore, she had not been in contact with any person returning from Wuhan (except Case 3/4/5). In particular, Case 1 did not present any symptoms until Feb. 1. She became ill with fever and a non-productive cough; she took drugs at that time. By the evening, Case 1 started feeling better and continued to enjoy the Spring Festival. However, two days later, a fever of 38.6 °C recurred, along with dizziness, non-productive cough, and shortness of breath. She was brought to the hospital by her son on Feb. 4 ([Fig. 2](#fig0010){ref-type="fig"}). The laboratory examination revealed an increased level of white blood cell count (12.4 × 10^9^/L), neutrophil count (7.82 × 10^9^/L), C-reactive protein level (189.2 mg/L) and a low lymphocyte count (0.84 × 10^9^/L) and platelet count (88 × 10^9^/L) ([Table 1](#tbl0005){ref-type="table"}). CT images showed massive shadows of high density in the lungs ([Fig. 1](#fig0005){ref-type="fig"} ). Case 1 developed severe pneumonia and was placed in the ICU as dyspnoea increased, with hypoxemia on day two of hospitalization. As of Feb. 15, her clinical condition had improved, and her oxygen saturation values recovered to 94% on supplemental oxygen. A nasopharyngeal and an oropharyngeal swab obtained on admission day ten remained positive for SARS-CoV-2 ([Table 2](#tbl0010){ref-type="table"} ).Fig. 1Respectively, the chest CT images of five Cases. (A) Massive shadows of high density of Case 1. (B/D) No abnormalities of Case 2 and Case 4. (C/E) Ground-glass changes of Case 3 and Case 5.Fig. 1Table 2Results of rRT-PCR test for SARS-CoV-2 nucleic acid.Table 2SpecimenCase 1Case 2Case 3Case 4Case 5DateFeb. 4Feb. 14Feb. 5Feb. 12Feb. 5Feb. 15Feb. 5Feb. 15Feb. 5Feb. 15Nasopharyngeal swabNA+ (Ct 37)+ (Ct 30)−+ (Ct 22)+ (Ct 33)+ (Ct 26)−NA+ (Ct 37)Oropharyngeal swab+ (Ct 19)+ (Ct 35)+(Ct 23)+(Ct 38)+ (Ct 21)+(Ct 31)NA−+ (Ct 21)+ (Ct 34)SerumND−NDNAND−ND−NDNAUrineNDNDNDNDNDNDNDNDNDNDStoolNDNANDNDNDNDND−NDND[^3]

Case 2, a 28-year-old man, was living in Luzhou. He had not come to an area where COVID-19 was spreading or had contact with any fever or pneumonia patients. He had just attended the family reunion dinner with his family members, including his mother (Case 1)/uncle (Case 3)/aunt (Case 4)/cousin(Case 5), on Jan 23 through 25. After his diagnosis of COVID-19, he never had an elevated temperature, and there were no abnormal symptoms except an increased level of C-reactive protein (10.5 mg/L) and a reduced lymphocyte count (1.03 × 10^9^/L). Chest CT images showed no significant abnormalities ([Fig. 1](#fig0005){ref-type="fig"}).

On Jan. 22, Case 4, a migrant who did business in Wuhan, drove back to Luzhou with Case 3 and Case 5 for the Spring Festival. On Feb 5, she also was admitted to the hospital, and a nasopharyngeal swab was positive for SARS-CoV-2 (Ct values, 26). Her chest CT images were standard ([Fig. 1](#fig0005){ref-type="fig"}). From Jan 22 to Feb. 4, Case 4 did not present any symptoms until 7 PM on Feb 5. She started having slight pharyngalgia and diarrhea (3--5 times per day) without an increased body temperature or cough.

Laboratory examination indicated an elevated C-reactive protein (43.5 mg/L), and decreased platelet count (72 × 10^9^/L). Case 4 was started on oxygen support at 2 L/min and was treated with oseltamivir (75 mg every 12 h), dioctahedral smectite powder (3 g every 8 h) and cefixime (100 mg every 12 h). Two days later, she felt better. Her rRT-PCR results were negative on Feb 15 ([Table 2](#tbl0010){ref-type="table"}).

Case 3 and Case 5 are previously healthy men without a history of hypertension or type 2 diabetes. On days three through five of hospitalization, they developed fever and cough symptoms. Chest CT scans showed ground-glass opacities in the lungs ([Fig. 1](#fig0005){ref-type="fig"}), and other laboratory examinations showed mildly decreased lymphocyte counts ([Table 1](#tbl0005){ref-type="table"}) and increased C-reactive protein (9.0/24.7 mg/L). Their infections were moderate. Although their symptoms had resolved except for the cough, they remained hospitalized because their rRT-PCR test results were positive as of Feb. 15 ([Table 2](#tbl0010){ref-type="table"}).

4. Discussion {#sec0020}
=============

COVID-19 has been proven to be transmitted through the respiratory tract, digestive system, and mucosal surfaces (such as the conjunctiva) ([@bib0010], [@bib0060]). Nosocomial infections in healthcare facilities also occur and highlight the significance of effective infection control ([@bib0080]). At the onset, the symptoms are usually fever, cough, shortness of breath, and pharyngalgia or diarrhea ([@bib0035]). The emblematic radiologic characteristic is ground-glass opacities in the lungs. Laboratory data present as lymphocytopenia, hypoxemia, thrombocytopenia, and even liver and kidney dysfunction in severe pneumonia patients ([@bib0020]). At present, verified patients are the primary sources of infection, however asymptomatic carriers can also be a source to propagate the outbreak. These patients are not easy to detect when initially infected but may have abnormal symptoms later ([@bib0020]).

In this familial cluster of five patients associated with COVID-19 in Luzhou, China, Case 1 had contact with only her family members (Case 2/3/4/5), some of them must be asymptomatic carriers of COVID 19. It is certain that Case 2 through 5 had no abnormal symptoms before the outbreak of Case 1. Notably, COVID-19 is highly infectious and may be transmitted by asymptomatic carriers during the incubation period. The timeline events suggest that Case 4 was the most likely initial infection source, as the time of the onset of symptoms and negative rRT-PCR results was relatively earlier than Case 3 and Case 5 ([Fig. 2](#fig0010){ref-type="fig"} ). Case 2 was afebrile without any clinical signs, and his chest CT images showed no abnormalities on Feb. 5 and Feb. 15 ([Fig. 1](#fig0005){ref-type="fig"}), which also proved the existence of asymptomatic carriers. Our findings provide evidence that asymptomatic carriers can be a latent source of COVID-19 infection. As the spread of COVID-19 is worsening worldwide, it is pressing to provide more information for an improved understanding of both the transmission and precautions to take to deal with COVID-19. Further studies on the mechanism in which asymptomatic carriers can acquire and transmit COVID-19 are warranted.Fig. 2Timeline of exposure to the asymptomatic carrier of COVID-19 which leads to a familial cluster infection.Fig. 2
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